000 | a | ||
---|---|---|---|
999 |
_c18368 _d18368 |
||
003 | OSt | ||
005 | 20221130101333.0 | ||
008 | 221130b xxu||||| |||| 00| 0 eng d | ||
040 |
_aAIKTC-KRRC _cAIKTC-KRRC |
||
100 |
_98509 _aPhimarn, W. |
||
245 | _aEfficacy and safety of baclofen for treatment of alcohol dependence: an updated meta-analysis and meta-regression study | ||
250 | _aVol.84(1), Jan-Feb | ||
260 |
_aMumbai _bIndian Journal of Pharmaceutical Science _c2022 |
||
300 | _a137-149p. | ||
520 | _aBaclofen is increasingly used for alcohol dependence treatment but its use remains controversial. Therefore, this study aimed to assess the efficacy and safety of baclofen use on alcohol dependence. This is systematic review and meta-analysis of randomized controlled trials. PubMed, Science Direct, Scopus and Thai databases were systematically searched. Randomized controlled trials investigating efficacy and safety of baclofen on alcohol dependence were included. Study selection, data extraction and quality assessment were performed independently by two reviewers. The clinical therapeutic efficacy and adverse events of baclofen were assessed and were pooled using a random-effects model. Heterogeneity was assessed by I 2 and chi-squared test. Sixteen studies with 1539 alcohol dependence patients were included. Baclofen increased risk of abstinence (risk ratio=1.32; 95 % confidence interval: 1.12, 1.55; p=0.0006) and abstinence duration (standard mean difference=1.07 d (95 % confidence interval: 0.13, 2.01; p=0.04) significantly. Moreover, baclofen significantly decreased heavy drinking days (standard mean difference=-1.14 d; 95 % confidence interval:-1.95, -0.34; p=0.007). However, there were no significant effects on times to relapse, craving and number of alcohol drinks. No serious adverse event associated with baclofen was reported during treatments. The meta-regression found baclofen dose was significantly associated with craving. This meta-analysis indicated that baclofen treatment in alcohol dependence patients is associated with better outcomes in risk of abstinence, abstinence duration and heavy drinking days. However, larger well- designed studies are required to confirm these conclusions. | ||
650 | 0 |
_94639 _aPHARMACEUTICS |
|
700 |
_919279 _aChamnanjit, P. |
||
773 | 0 |
_tIndian journal of pharmaceutical sciences _dNew Delhi |
|
856 |
_uhttps://www.ijpsonline.com/articles/efficacy-and-safety-of-baclofen-for-treatment-of-alcohol-dependence-an-updated-metaanalysis-and-metaregression-study.pdf _yClick here |
||
942 |
_2ddc _cAR |